News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
588,889 Results
Type
Article (49355)
Company Profile (111)
Press Release (539423)
Section
Business (162570)
Career Advice (2520)
Deals (29409)
Drug Delivery (110)
Drug Development (76073)
Employer Resources (146)
FDA (14615)
Job Trends (13194)
News (289150)
Policy (29259)
Tag
Academia (2720)
Alliances (42352)
Alzheimer's disease (1360)
Approvals (14581)
Artificial intelligence (223)
Bankruptcy (320)
Best Places to Work (10664)
Breast cancer (226)
Cancer (1722)
Cardiovascular disease (148)
Career advice (2114)
CAR-T (128)
Cell therapy (368)
Clinical research (61121)
Collaboration (633)
Compensation (209)
COVID-19 (2651)
C-suite (179)
Data (1631)
Diabetes (215)
Diagnostics (6503)
Earnings (57276)
Employer resources (133)
Events (79711)
Executive appointments (589)
FDA (15504)
Funding (594)
Gene therapy (259)
GLP-1 (694)
Government (4413)
Healthcare (17003)
Infectious disease (2771)
Inflammatory bowel disease (120)
Interviews (533)
IPO (13181)
Job creations (2934)
Job search strategy (1736)
Layoffs (424)
Legal (6302)
Lung cancer (262)
Manufacturing (231)
Medical device (11434)
Medtech (11438)
Mergers & acquisitions (16562)
Metabolic disorders (588)
Neuroscience (1806)
NextGen: Class of 2025 (6001)
Non-profit (4293)
Northern California (1840)
Obesity (320)
Opinion (214)
Patents (166)
People (52376)
Phase I (18860)
Phase II (26821)
Phase III (20369)
Pipeline (759)
Postmarket research (2532)
Preclinical (7952)
Radiopharmaceuticals (218)
Rare diseases (328)
Real estate (4885)
Regulatory (20295)
Research institute (2350)
Resumes & cover letters (371)
Southern California (1640)
Startups (3077)
United States (16527)
Vaccines (621)
Weight loss (236)
Date
Today (8)
Last 7 days (712)
Last 30 days (2311)
Last 365 days (31145)
2025 (4734)
2024 (31963)
2023 (35883)
2022 (46575)
2021 (50287)
2020 (49324)
2019 (42457)
2018 (32170)
2017 (29202)
2016 (28254)
2015 (32757)
2014 (24885)
2013 (20851)
2012 (22213)
2011 (23155)
2010 (20996)
Location
Africa (814)
Arizona (160)
Asia (35843)
Australia (7320)
California (4232)
Canada (1608)
China (373)
Colorado (203)
Connecticut (198)
Europe (81116)
Florida (660)
Georgia (159)
Illinois (407)
Indiana (242)
Japan (116)
Maryland (696)
Massachusetts (3090)
Michigan (182)
Minnesota (275)
New Jersey (1239)
New York (1236)
North Carolina (773)
Northern California (1840)
Ohio (160)
Pennsylvania (960)
South America (1108)
Southern California (1640)
Texas (649)
Utah (146)
Washington State (420)
588,889 Results for "heartsciences formerly known as heart test labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
Heart Test Laboratories, Inc.d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) today reported financial results for the third quarter fiscal 2024 ended January 31, 2024 and provided a business update.
March 14, 2024
·
8 min read
Lone Star Bio
HeartSciences to Present at the LD Micro Invitational XIV Conference
Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson is scheduled to present at the LD Micro Invitational XIV Conference on Tuesday April 9, 2024 at 5:00pm ET at the Sofitel New York.
April 2, 2024
·
3 min read
Lone Star Bio
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”) today announced that the Canadian Intellectual Property Office Application No. 3,000,369 has been granted by the Canadian Intellectual Property Office.
March 6, 2024
·
4 min read
Press Releases
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
December 16, 2024
·
8 min read
Business
HeartSciences Expands its Scientific Advisory Board
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence -powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced the appointment of Jordan B. Strom M.D., M.Sc., to its Scientific Advisory Board.
February 12, 2024
·
5 min read
Lone Star Bio
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence -powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced the publication, in Cardiovascular Diabetology, of an independent, peer-reviewed study utilizing its MyoVista® proprietary technology.
March 12, 2024
·
5 min read
Business
HeartSciences Appoints New Scientific Advisory Board Member
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence -powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced the appointment of Benjamin Glicksberg, Ph.D. to its Scientific Advisory Board.
February 1, 2024
·
4 min read
Business
HeartSciences Reports Second Quarter Fiscal 2024 Financial Results
Heart Test Laboratories, Inc.d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) today reported financial results for the second quarter fiscal 2024 ended October 31, 2023 and provided a business update.
December 14, 2023
·
7 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
July 12, 2024
·
4 min read
1 of 58,889
Next
